Prostate surgery after penile prosthesis implantation presents no contraindications—oncologic (prostatectomy) or benign (BPH) procedures via endoscopic, laparoscopic, or robotic approaches proceed safely. Patients must inform the urologist about the implant for procedural facilitation, assuming surgeon competence with prosthetic devices .
Prostate surgery after penile prosthesis compatibility stems from anatomical separation: cylinders reside in corpora cavernosa, distant from prostate/urethra. TURP, HoLEP, and robotic prostatectomies access posterior urethra without cylinder interference. Reservoir in Retzius space (infrapubic approach) rarely encountered during RALP (<2% cases) .
Prostate surgery after penile prosthesis timing considerations:
Reservoir identification: Space of Retzius palpation/digital exam
No deflation required: Surgery proceeds with partial inflation
Antibiotics: Standard prostate + prosthesis prophylaxis
Prostate surgery after penile prosthesis postoperative management unchanged: early catheter removal, Kegel exercises compatible with cycling, PSA surveillance normal. Implant function preserved 98% cases; rare cylinder erosion from prolonged catheterization addressed via capsulotomy .
Prostate surgery after penile prosthesis patient counseling clarifies:
Timing: No rush unless oncologic urgency
Risk: Equivalent to non-implanted peers
Function: Prosthesis unaffected by prostate intervention
Continence: Sling/AJUST compatible post-RP if needed
Long-term prostate surgery after penile prosthesis data shows 95% implant survival at 5 years post-TURP, 92% post-RP. Mechanical failure rates unchanged. Oncologic control equivalent; PSA trends match non-implanted controls. High-volume centers report zero implant-related complications .
Prostate surgery after penile prosthesis represents standard urologic practice: 25% implant patients require prostate intervention within 10 years. Surgeon familiarity eliminates technical barriers. Disclosure ensures optimal execution—failure to inform risks unnecessary dissection or antibiotic omission .
Prostate surgery after penile prosthesis transforms patient management: ED treatment no longer precludes BPH/oncologic care. Comprehensive urologic planning coordinates implant timing with PSA surveillance, ensuring functional restoration precedes prostate intervention when appropriate. Dual pathology managed seamlessly .
